Garner Health raised $100 million in a Series E round led by Index Ventures with participation from Kleiner Perkins, Redpoint, Thrive, Sequoia, Founders Fund, and Kaiser Permanente Ventures. The company aims to connect patients with high-performing doctors, positioning the round as support for scaling its healthcare network model. Countable Labs closed a $26 million financing round to expand its single-molecule PCR technology and apply it to MRD and cell and gene therapy-related applications. The capital is intended to support commercialization and solution development beyond current deployments. These fundraises reinforce investor appetite for infrastructure and workflow-enabling tools in diagnostics and patient routing, not only for drug pipelines.